BDP8900
BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells[1].
Product Specifications
CAS Number
2226507-05-5
UNSPSC
12352005
Target
Cdc42-binding kinase
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bdp8900.html
Smiles
N1(C2=CC=NC3=C2C(C4=NC=CS4)=CN3)C[C@]5(CCCCN5)CCC1
Molecular Formula
C19H23N5S
Molecular Weight
353.48
References & Citations
[1]Discovery of potent and selective MRCK inhibitors with therapeutic effect on skin cancer
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MRCKβ
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
25314091 4x 500 ng
KBTBD13-set siRNA/shRNA/RNAi Lentivector (Human)
Sign In for Pricing
View Details MBS6190193-01 0.1 mL
FLVCR (Feline Leukemia Virus Subgroup C Receptor-related Protein 1, Feline Leukemia Virus Subgroup C Receptor, hFLVCR, FLVCR1) (MaxLight 405)
Sign In for Pricing
View Details MBS6190193-02 5x 0.1 mL
FLVCR (Feline Leukemia Virus Subgroup C Receptor-related Protein 1, Feline Leukemia Virus Subgroup C Receptor, hFLVCR, FLVCR1) (MaxLight 405)
Sign In for Pricing
View Details TRV-0005985-01 24 Tests
ELISA Kit for Transforming Growth Factor Beta 2 (TGFb2)
Sign In for Pricing
View Details TRV-0005985-02 48 Tests
ELISA Kit for Transforming Growth Factor Beta 2 (TGFb2)
Sign In for Pricing
View Details